<div id="readability-page-1"><p>Edgestream Partners L.P. increased its position in  Exponent, Inc. (NASDAQ:EXPO - Free Report) by 48.6% in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 113,330 shares of the business services provider's stock after buying an additional 37,057 shares during the quarter. Edgestream Partners L.P. owned 0.22% of Exponent worth $8,467,000 as of its most recent filing with the Securities and Exchange Commission (SEC).</p><ul><li>7 best fintech ETFs to buy now</li></ul><p>Several other hedge funds and other institutional investors have also bought and sold shares of the company. Kayne Anderson Rudnick Investment Management LLC raised its stake in shares of  Exponent by 1.2% during the first quarter. Kayne Anderson Rudnick Investment Management LLC now owns 4,791,747 shares of the business services provider's stock worth $388,419,000 after acquiring an additional 55,190 shares in the last quarter.  Geneva Capital Management LLC grew its holdings in shares of  Exponent by 7.6% during the 2nd quarter. Geneva Capital Management LLC now owns 1,877,765 shares of the business services provider's stock valued at $140,288,000 after purchasing an additional 131,937 shares during the last quarter.  Geode Capital Management LLC raised its position in  Exponent by 1.3% in the 2nd quarter. Geode Capital Management LLC now owns 1,597,542 shares of the business services provider's stock worth $119,360,000 after purchasing an additional 21,272 shares during the period.  JPMorgan Chase &amp; Co. lifted its stake in  Exponent by 25.1% in the second quarter. JPMorgan Chase &amp; Co. now owns 638,081 shares of the business services provider's stock worth $47,671,000 after purchasing an additional 128,131 shares during the last quarter.  Finally, Resona Asset Management Co. Ltd. boosted its position in  Exponent by 17.6% during the second quarter. Resona Asset Management Co. Ltd. now owns 596,118 shares of the business services provider's stock valued at $44,442,000 after buying an additional 89,334 shares during the period. Hedge funds and other institutional investors own  92.37% of the company's stock. </p><h2>Wall Street Analysts Forecast Growth</h2><p>Several research firms have recently commented on EXPO. William Blair upgraded Exponent from a &#34;market perform&#34; rating to an &#34;outperform&#34; rating in a report on Monday, November 17th. Weiss Ratings  reaffirmed a &#34;hold (c-)&#34; rating on shares of Exponent in a research note on Wednesday, October 8th. One equities research analyst  has rated the stock with a Buy rating and one  has issued  a Hold rating to the stock. According to data from MarketBeat, Exponent  has an average rating of &#34;Moderate Buy&#34;.</p><ul><li>How to Buy OpenAI Stock: A Guide</li></ul><p><b>View Our Latest Analysis on EXPO</b></p><h2>Exponent Stock Performance</h2><p>Shares of EXPO stock opened at $73.13 on Tuesday. Exponent, Inc. has a fifty-two week low of $63.81 and a fifty-two week high of $99.72. The firm has a market cap of $3.65 billion, a P/E ratio of 36.57 and a beta of 0.91. The business's 50 day moving average price is $69.22 and its 200-day moving average price is $71.93. </p><ul><li>How to Calculate Moving Average; How it Helps in Stock Selection</li></ul><p>Exponent (NASDAQ:EXPO - Get Free Report) last announced its quarterly earnings results on Thursday, October 30th. The business services provider reported $0.55 EPS for the quarter, topping analysts' consensus estimates of $0.50 by $0.05. The company had revenue of $147.12 million during the quarter, compared to analyst estimates of $131.78 million. Exponent had a return on equity of 24.19% and a net margin of 18.35%.The firm's revenue was up 9.6% on a year-over-year basis. During the same quarter last year, the firm posted $0.50 earnings per share.  As a group, equities analysts predict that  Exponent, Inc. will post 1.98 EPS for the current year. </p><h2>Exponent Dividend Announcement</h2><p>The business also recently declared a quarterly dividend, which will be paid on Friday, December 19th. Investors of record on Friday, December 5th will be given a dividend of $0.30 per share. The ex-dividend date is Friday, December 5th. This represents a $1.20 annualized dividend and a dividend yield of 1.6%. Exponent's payout ratio is currently 58.54%. </p><p>Exponent declared that its Board of Directors has initiated a stock repurchase program on Thursday, October 30th that permits the company to repurchase $100.00 million in    shares. This repurchase authorization permits the business services provider to buy up to 3% of its shares through open market purchases. Shares repurchase programs are generally a sign that the company's board believes its shares are undervalued. </p><h2>Insider Transactions at Exponent</h2><p>In related news, CEO Catherine Corrigan sold 4,930 shares of the stock in a transaction dated Wednesday, October 15th. The shares were sold at an average price of $66.82, for a total value of $329,422.60. Following the completion of the transaction, the chief executive officer directly owned 82,753 shares of the company's stock, valued at $5,529,555.46. This represents a 5.62% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities &amp; Exchange Commission, which is available at this link. Insiders have sold 14,735 shares of company stock valued at $1,017,242 over the last ninety days. 1.60% of the stock is owned by corporate insiders. </p><h2>Exponent Profile</h2> (Free Report)<p>Exponent, Inc, together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health. The Engineering and Other Scientific segment provides services in the areas of biomechanics, biomedical engineering and sciences, buildings and structures, civil engineering, construction consulting, data sciences, electrical engineering and computer science, human factors, materials and corrosion engineering, mechanical engineering, polymer science and materials chemistry, thermal sciences, and vehicle engineering.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Exponent</li><li>What Investors Need to Know About Upcoming IPOs</li><li>Up Over 20% in 2025, These 3 Stocks Are Boosting Buyback Capacity</li><li>Pros And Cons Of Monthly Dividend Stocks</li><li>Congress Beat the Market Again—Here Are the 3 Stocks They Bought</li><li>Breakout Stocks: What They Are and How to Identify Them</li><li>Go on a Shopping Spree With 3 Top Retail ETFs</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RVhQTw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9RVhQTw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Exponent Right Now?</h2><p>Before you consider Exponent, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exponent wasn't on the list.</p><p>While Exponent currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

EXPO

<p>Edgestream Partners L.P. increased its stake in Exponent, Inc. by 48.6% in Q2, owning 113,330 shares worth $8.47 million. Other institutional investors also adjusted their positions in Exponent. The company reported Q3 earnings of $0.55 per share, exceeding estimates, with revenue up 9.6% year-over-year. Exponent announced a $1.20 annual dividend and a $100 million stock repurchase program, indicating confidence in its valuation.</p>

Edgestream Partners L.P. Purchases 37,057 Shares of Exponent, Inc. $EXPO